Glucagon-Like Peptide-2 Improves Both Acute and Late Experimental Radiation Enteritis in the Rat

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1563-1571

  Torres, Sandra ^a,b   Thim, Lars ^c   Milliat, Fabien ^a,b   Vozenin Brotons, Marie Catherine ^a,b   Olsen, Ulfe Bang ^c   Ahnfelt Rønne, Ian ^c   Bourhis, Jean ^a   Benderitter, Marc ^b   François, Agnès ^a,b  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b SRBE   (France)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Consequential late effect; Fibrosis; Glucagon like peptide 2; Mucosal ulceration; Radiation enteritis

Indexed keywords

IRRADIATION; MICROSCOPIC EXAMINATION; ONCOLOGY; PEPTIDES; RATS;

CHRONIC RADIATION ENTERITIS; CONSEQUENTIAL LATE EFFECTS; MUCOSAL DISRUPTION; MUCOSAL ULCERATION;

RADIOTHERAPY;

GLUCAGON LIKE PEPTIDE 2; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; INTESTINE CRYPT; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE ULCER; INTESTINE VILLUS; INTESTINE WALL; MALE; NONHUMAN; PELVIS CANCER; PRIORITY JOURNAL; RADIATION ENTEROPATHY; RADIATION EXPOSURE; RADIATION INJURY; RAT; RISK REDUCTION; SINGLE DRUG DOSE; SMOOTH MUSCLE FIBER; TREATMENT RESPONSE; WOUND HEALING; X RAY;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DRUG EVALUATION, PRECLINICAL; ENTERITIS; GLUCAGON-LIKE PEPTIDE 2; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; RADIATION INJURIES, EXPERIMENTAL; RATS; RATS, WISTAR;

EID: 36148939463     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.08.051     Document Type: Article

References (52)

1. Rubin P., and Casarett G. Clinical radiation pathology as applied to curative radiotherapy. Cancer 22 (1968) 767-778
2. Berthrong M., and Fajardo L.F. Radiation injury in surgical pathology. Part II. Alimentary tract. Am J Surg Pathol 5 (1981) 153-178
3. Cengiz M., Akbulut S., Atahan I.L., et al. Acute phase response during radiotherapy. Int J Radiat Oncol 49 (2001) 1093-1096
4. Coia L.R., Myerson R.J., and Tepper J.E. Late effects of radiation therapy on the gastro-intestinal tract. Int J Radiat Oncol 31 (1995) 1213-1236
5. Rubio C.A., and Jalnas M. Dose-time-dependent histological changes following irradiation of the small intestine of rats. Digest Dis Sci 41 (1996) 392-401
6. Quastler H. The nature of intestinal radiation death. Radiat Res 4 (1956) 303-320
7. Novak J.M., Collins J.T., Donowitz M., et al. Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol 1 (1979) 9-39
8. Paris F., Fuks Z., Kang A., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293 (2001) 293-297
9. Potten C.S., Owen G., and Roberts S.A. The temporal and special changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol 57 (1990) 185-199
10. Denham J.W., Hauer-Jensen M., and Peters L.J. Is it time for a new formalism to categorize normal tissue radiation injury?. Int J Radiat Oncol Biol Phys 50 (2001) 1105-1106
11. Dörr W., and Hendry J.H. Consequential late effects in normal tissues. Radiother Oncol 61 (2001) 223-231
12. Potten C.S., Owen G., Hewitt D., et al. Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut 36 (1995) 864-873
13. Dörr W., Noack R., Spekl K., et al. Modification of oral mucositis by keratinocyte growth factor: Single radiation exposure. Int J Radiat Biol 77 (2001) 341-347
14. Sonis S.T., Costa Jr. J.W., Evitts S.M., et al. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 74 (1992) 749-755
15. Sonis S.T., Lindquist L., Van Vugt A., et al. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res 54 (1994) 1135-1138
16. L'Heureux M.C., and Brubaker P.L. Therapeutic potential of the intestinotropic hormone, glucagon-like peptide-2. Ann Med 33 (2001) 229-235
17. Stevens F.M., Flanagan R.W., O'Gorman D., et al. Glucagonoma syndrome demonstrating giant duodenal villi. Gut 25 (1984) 784-791
18. Drucker D.J., Ehrlich P., Asa S.L., et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93 (1996) 7911-7916
19. Tsai C.H., Hill M., Asa S.L., et al. Intestinal growth promoting properties of glucagon-like peptide-2 in mice. Am J Physiol 273 (1997) E77-E84
20. Burrin D.G., Stoll B., Guan X., et al. GLP-2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 146 (2005) 22-32
21. Xiao Q., Boushey R.P., Cino M., et al. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. Am J Physiol 278 (2000) R1057-R1063
22. Chance W.T., Foley-Nelson T., Thomas I., et al. Prevention of parenteral nutrition-induced gut hypoplasia by confusion of glucagon-like peptide-2. Am J Physiol 273 (1997) G559-G563
23. Martin G.R., Wallace L.E., and Sigalet D.L. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol 286 (2004) G964-G972
24. L'Heureux M.C., and Brubaker P.L. Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis. J Pharmacol Exp Ther 306 (2003) 347-354
25. Boushey R.P., Yusta B., and Drucker D.J. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced enteritis. Am J Physiol 277 (1999) E937-E947
26. Boushey R.P., Yusta B., and Drucker D.J. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res 61 (2001) 687-693
27. Booth C., Booth D., Williamsom S., et al. Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage. Cell Prolif 37 (2004) 385-400
28. Drucker D.J., Shi Q., Crivici A., et al. Regulation of the biological activity of glucagon-like peptide-2 in vivo by dipeptidylpeptidase IV. Nat Biotechnol 15 (1997) 673-677
29. Mentlein R. Dipeptidyl-peptidase IV (CD26)-Role in the inactivation of regulatory peptides. Regul Pept 85 (1999) 9-24
30. Hartman B., Thulesen J., Kissow H., et al. Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology 141 (2000) 4013-4020
31. Walsh N.A., Yusta B., Dacambra M.P., et al. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology 144 (2003) 4385-4392
32. Farrell C.L., Bready J.V., Rex K.L., et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58 (1998) 933-939
33. Howarth G.S., Fraser R., Frisby C.L., et al. Effects of insulin-like growth factor-I administration on radiation enteritis in rats. Scand J Gastroenterol 32 (1997) 1118-1124
34. McKenna K.J., Ligato S., Kauffman Jr. G.L., et al. Epidermal growth factor enhances intestinal mitotic activity and DNA content after acute abdominal radiation. Surgery 115 (1994) 626-632
35. Khan W.B., Shui C., Ning S., et al. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res 148 (1997) 248-253
36. Becker J.C., Beckbauer M., Domchke W., et al. Fibrin glue, healing of gastric mucosal injury, and expression of growth factors: Results from a human in vivo study. Gastrointest Endosc 61 (2005) 560-567
37. Sigalet D.L., Wallace L.E., Holst J.J., et al. Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol 293 (2007) G211-G221 Epub 29 Mar 2007
38. Nusrat A., Delp C., and Madara J.L. Intestinal epithelial restitution. J Clin Invest 89 (1992) 1501-1511
39. Bulut K., Meier J.J., Ansorge N., et al. Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro evidence for a TGF-β-mediated pathway. Reg Pept 121 (2004) 137-143
40. Ramsanahie A.P., Perez A., Duensing A.U., et al. Glucagon-like peptide 2 enhances intestinal epithelial restitution. J Surg Res 107 (2002) 44-49
41. Orskov C., Hartmann B., Poulsen S.S., et al. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Reg Pept 124 (2005) 105-112
42. Scott R.B., Kirk D., MacNaughton W.K., et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol 275 (1998) G911-G921
43. Ljungmann K., Hartmann B., Kissmeyer-Nielsen P., et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol 281 (2001) G779-G785
44. François A., Milliat F., Vozenin-Brotons M.C., et al. "In-field" and "out-of-field" functional impairment during sub-acute and chronic phases of experimental radiation enteropathy in the rat. Int J Radiat Biol 79 (2003) 437-450
45. Wang J., Zheng H., Sung C.C., et al. The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int J Radiat Oncol Biol Phys 45 (1999) 1289-1296
46. Wang J., Albertson C.M., Zheng H., et al. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine. Thromb Haemost 87 (2002) 122-128
47. Wang J., Zheng H., Ou X., et al. Hirudin ameliorates intestinal radiation toxicity in the rat: Support for thrombin inhibition as strategy to minimize side-effects after radiation therapy and as countermeasure against radiation exposure. J Thromb Haemost 2 (2004) 2027-2035
48. Denham J.W., Peters L.J., Johansen J., et al. Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer?. Radiother Oncol 52 (1999) 157-164
49. Chai J., Baatar D., and Tarnawski A. Serum response factor promotes re-epitheliazation and muscular structure restoration during gastric ulcer healing. Gastroenterology 126 (2004) 1809-1818
50. Shin E.D., Estall J.L., Izzo A., et al. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide 2. Gastroenterology 128 (2005) 1340-1353
51. Chance W.T., Sheriff S., Foley-Nelson T., et al. Maintaining gut integrity during parenteral nutrition of tumor-bearing rats: Effects of glucagon-like peptide 2. Nutr Cancer 37 (2000) 215-222
52. Thulesen J., Hartmann B., Hare K.J., et al. Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut 53 (2004) 1145-1150